81 related articles for article (PubMed ID: 1818519)
1. The soluble interleukin-2 receptor as a new biological marker in diseases.
Pizzolo G
Allergol Immunopathol (Madr); 1991; 19(4):176-80. PubMed ID: 1818519
[No Abstract] [Full Text] [Related]
2. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
Zerler B
Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
[TBL] [Abstract][Full Text] [Related]
3. The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation.
Gascoigne AD; Shenton BK; White MD; Colquhoun IW; Dark JH; Corris PA
Transplantation; 1993 Oct; 56(4):1029-31. PubMed ID: 8212185
[No Abstract] [Full Text] [Related]
4. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA
Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568
[No Abstract] [Full Text] [Related]
5. The soluble interleukin-2 receptor: a new humoral marker in hematological malignancies.
Frydecka I; Kuliczkowski K
Acta Haematol Pol; 1991; 22(2):327-30. PubMed ID: 1841506
[No Abstract] [Full Text] [Related]
6. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
Noronha IL; Daniel V; Rambausek M; Waldherr R; Opelz G
Transplant Proc; 1990 Aug; 22(4):1859-60. PubMed ID: 2117814
[No Abstract] [Full Text] [Related]
7. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
[No Abstract] [Full Text] [Related]
8. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
[No Abstract] [Full Text] [Related]
9. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
[No Abstract] [Full Text] [Related]
10. Serum immunosuppressive acidic protein as an immune parameter following renal transplantation.
Koyama I; Taguchi Y; Watanabe T; Nagashima N; Kadokura M; Omoto R
Transplant Proc; 1994 Aug; 26(4):2157-8. PubMed ID: 8066707
[No Abstract] [Full Text] [Related]
11. Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation.
De Maria R; Zuccelli GC; Masini S; Caroli A; Brando B; Gronda E; Donato L
Transplant Proc; 1989 Feb; 21(1 Pt 1):440-1. PubMed ID: 2650169
[No Abstract] [Full Text] [Related]
12. Appearance of cells bearing the interleukin-2 receptor in peripheral blood of cardiac transplant patients and their correlation with rejection episodes.
Coles M; Rose M; Yacoub M
Transplant Proc; 1987 Feb; 19(1 Pt 3):2546-7. PubMed ID: 3274559
[No Abstract] [Full Text] [Related]
13. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients.
Colvin RB; Preffer FI; Fuller T; Brown M; Ip S; Kung P; Cosimi AB
Transplant Proc; 1989 Feb; 21(1 Pt 2):1863. PubMed ID: 2652605
[No Abstract] [Full Text] [Related]
14. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients.
Möhring K; Pomer S; Daniel U; Rambausek M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470
[No Abstract] [Full Text] [Related]
15. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
[No Abstract] [Full Text] [Related]
16. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
Akimoto Y; Ishiyama T; Ueno H; Hino K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1995 Nov; 36(11):1247-51. PubMed ID: 8691563
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases].
Sugimoto H; Hashimoto N; Suzuki S; Gejyo F
Rinsho Byori; 1996 Feb; 44(2):176-82. PubMed ID: 8851203
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 receptor in rat allograft rejection.
Bouchot O; Anegon I; Romaniuk A; Jacques Y; Soulillou JP
Transplant Proc; 1990 Aug; 22(4):1995-7. PubMed ID: 2202134
[No Abstract] [Full Text] [Related]
20. Determination of soluble IL-2 receptors in kidney graft recipients--a 6-month follow-up.
Manfro RC; Pohanka E; Tomlanovich SJ; Benet LZ; Salvatierra O; Garovoy MR
Transplant Proc; 1990 Aug; 22(4):1861-2. PubMed ID: 2389461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
